{"id":"W2948436219","doi":"10.1056/nejmoa1815281","title":"Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":852,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute; Novo Nordisk Fonden","keywords":"Venetoclax; Obinutuzumab; Medicine; Ibrutinib; Internal medicine; Oncology; Cancer research; Chronic lymphocytic leukemia; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001170426,0.0003250321,0.0008021895,0.0002237139,0.0003199693,0.0004239844,0.0003124209,0.0004692146,0.00175265],"category_scores_gemma":[0.0009682083,0.0001390778,0.000514428,0.0003819777,0.0003715653,0.0003143888,0.0002469904,0.0009661986,0.0001260402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005463848,"about_ca_system_score_gemma":0.0008270087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005598123,"about_ca_topic_score_gemma":0.001677678,"domain_scores_codex":[0.9996309,0.0001929994,0.00002517558,0.00005467014,0.00003711421,0.00005919296],"domain_scores_gemma":[0.9990366,0.0003397737,0.000277046,0.00004077895,0.00002931713,0.0002766647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5465925,0.01223629,0.09570597,0.00185225,0.001529378,0.0006514881,0.000444757,0.002682252,0.01898932,0.0004462202,0.002156096,0.3167135],"study_design_scores_gemma":[0.374539,0.4370373,0.1625312,0.0005145794,0.001968524,0.003036677,0.0002051846,0.002784741,0.005294368,0.0006168155,0.01141325,0.00005841537],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988325,0.01035541,0.00009747102,0.0001349476,0.00003294022,0.0001350596,0.0000901702,0.000009032887,0.0008199433],"genre_scores_gemma":[0.9973038,0.001658918,0.0003105311,0.000165807,0.00008256835,0.0001413801,0.0001517398,0.000001958543,0.0001832132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00175265,"threshold_uncertainty_score":0.006189883,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009446074225422615,"score_gpt":0.2713665505737163,"score_spread":0.2619204763482937,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}